Valvular & structural heart diseaseCohort study

Impact of Initial Valve Type on Reintervention for Transcatheter Aortic Valve Replacement (TAVR) Failure: From the EXPLANTORREDO-TAVR International Registry

Circ Cardiovasc IntervPublished

  • international registry
  • 29 centers

Authors' conclusion

Failed-BEV and failed-SEV showed distinct failure mechanisms and timing of reintervention, but initial valve type did not impact reintervention strategy or survival after redo-TAVR or TAVR-explant.

Study context

Population
Patients who underwent redo-TAVR or TAVR-explant for TAVR failure during a separate admission from index TAVR, May 2009 to February 2022; mechanically expanding valves and explantation for endocarditis excludedunderwent redo-TAVR or TAVR-explant for TAVR failure, 158 failed-BEV compared with 224 failed-SEV · failed-BEV 158 · failed-SEV 224
Participants
553 patients
Exposure
failed-BEV vs failed-SEV
  • failed-BEVn = 158reference
  • failed-SEVn = 224

Main finding

As reported in the abstract

Mortality · 30 days

P = 0.85

Observational data: associations, not effects.

Further findings

Mortality · 1 year

P = 0.65

Failure mechanism and time-to-reintervention

Structural valve deterioration

Prosthesis-patient mismatch

Paravalvular leak

Time-to-reintervention failed-BEV 41.8 months · failed-SEV 19.7 months

Reintervention strategy

redo TAVR

TAVR-explant

received SEV (cross-platform redo-TAVR) failed-BEV 58.1%

received BEV (cross-platform redo-TAVR) failed-SEV 59.2%

Outcomeadjusted hazard ratio (CI)P value
Risk-adjusted 3-year cumulative mortality, stratified by reintervention type · redo TAVR; ref: failed-BEV · no differences1.15 (0.61–2.20)
Risk-adjusted 3-year cumulative mortality, stratified by reintervention type · TAVR-explant · no differences0.84 (0.46–1.54)
  • Failure mechanism and time-to-reintervention: structural valve deterioration P <0.001
  • Failure mechanism and time-to-reintervention: prosthesis-patient mismatch P =0.022
  • Failure mechanism and time-to-reintervention: paravalvular leak P <0.001
  • Failure mechanism and time-to-reintervention: time-to-reintervention P <0.001
  • Reintervention strategy: strategy P =0.92
  • Reintervention strategy: cross-platform P =0.016

Baseline characteristics at reintervention

Mean age at reintervention
75.5±9.3 years
Female
40.6%

Original publication

Impact of Initial Valve Type on Reintervention for TAVR Failure: From the EXPLANTORREDO-TAVR International Registry. Circ Cardiovasc Interv. Published 11 September 2026. doi:10.1161/circinterventions.126.016705

Summarised from the published abstract; every number is checked against it